adverse event
105 results
1 - 100
pentosan- rosuvastatin
- anthrax vaccine (absorbed)
- licorice
- C1 inhibitor (human)
- angiotensin II
- mercaptopurine
- Detecting and Managing Adverse Drug Reactions
- bevacizumab
- abatacept
- peramivir
- rofecoxib
- varenicline (systemic)
- alendronate
- romiPLOStim
- phentermine
- C1-esterase inhibitor
- nintedanib
- thioguanine
- canagliflozin
- C1-esterase inhibitor, recombinant
- semaglutide
- necitumumab
- mixed pollens allergen extract
- timothy grass pollen allergen extract
- short ragweed pollen allergen extract
- azaTHIOprine
- follitropin alfa
- dextranomer/hyaluronate
- asparaginase Erwinia chrysanthemi
- bedaquiline
- lazertinib
- methotrexate
- phosphate/biphosphate
- methoxy polyethylene glycol-epoetin beta
- salsalate
- ziv-aflibercept
- daxibotulinumtoxinA
- fulvestrant
- IMMUNE GLOBULIN
- carfilzomib
- deflazacort
- porfimer
- iloprost
- burosumab
- fruquintinib
- alpha1-proteinase inhibitor, human
- osimertinib
- niMODipine
- liraglutide
- axitinib
- teplizumab
- naproxen/esomeprazole
- oxaliplatin
- maralixibat
- deucravacitinib
- ampicillin/sulbactam
- daprodustat
- naratriptan
- amivantamab
- Medication Errors: Improving Practices and Patient Safety
- trastuzumab
- cabozantinib
- trabectedin
- ado-trastuzumab
- upadacitinib
- pertuzumab
- avelumab
- vonoprazan
- Overview of Risk Evaluation and Mitigation Systems (REMS)
- boceprevir
- abrocitinib
- apalutamide
- relugolix/estradiol/norethindrone
- meloxicam
- Beers Criteria
- rituximab/hyaluronidase
- baricitinib
- ravulizumab
- capmatinib
- darunavir/cobicistat
- ipilimumab
- SUNItinib
- tapentadol